| ACE | Angiotensin Converting Enzyme Inhibitor |
| Akt | Protein Kinase B |
| AngII | Angiotensin II |
| ARB | Angiotensin Receptor Blocker |
| AP-1 | Activator Protein-1 |
| AT1R | Angiotensin Type 1 Receptor |
| BCL-6 | B-cell lymphoma-6 |
| c-Kit | Tyrosinkinase Kit |
| CLIC 4 | Cl−intracellular channel protein 4 |
| COX-2 | Cyclooxygenase-2 |
| CREB | C-AMP Response Element-binding protein |
| EGR | Early Growth Response Protein |
| eNOS | endothelial Nitric Oxide Synthase |
| ET-1 | Endothelin-1 |
| FAO | Fatty Acid Oxidation |
| FDA | Food and Drug Administration |
| GSK3β | glycogen synthase kinase 3β |
| HDL | High Density Lipoprotein |
| HETE | hydroxy eicosatetraenoic acid |
| HIF-1 | Hypoxia Inducible Factor 1 |
| HMG-CoA | 3-hydroxy-3-methylglutaryl coenzyme A |
| HO | Heme Oxygenase |
| ICAM-1 | Intercellular Adhesion Molecule-1 |
| IP-10 | IFN-inducible protein of 10 kDa |
| I-TAC | IFN-inducible T-cell alpha-chemoattractant |
| MAPK | Mitogen Activated Protein Kinase |
| MCP | Monocyte Chemoattractant Protein |
| MMP | Matrix Metallopeptidase |
| Mig | monokine induced by IFN-gamma |
| NADPH | nicotinamide adenine dinucleotide phosphate |
| NFκB | nuclear factor κB |
| NO | Nitric Oxide |
| NFAT | nuclear factor of activated T cells |
| PDGFR | Platelet-derived Growth Factor Receptor |
| PI3K | phosphoinositide 3-kinase |
| PPAR | Peroxisome proliferator activated receptor |
| PGE | Prostaglandin E |
| PKC | Protein Kinase C |
| rIPC | Remote Ischemic Preconditioning |
| RXR | Retinoid X Receptor |
| TSP | Thrombospondin |
| TF | Tissue Factor |
| TGF | Transforming Growth Factor |
| VCAM-1 | Vascular Cell Adhesion Molecule 1 |
| VEGF | Vascular Endothelial Growth Factor |
| VEGFR | Vascular Endothelial Growth Factor Receptor |